InvestorsObserver
×
News Home

Does Arcturus Therapeutics Holdings Inc (ARCT) Have What it Takes to be in Your Portfolio Wednesday?

Wednesday, June 07, 2023 01:30 PM | InvestorsObserver Analysts

Mentioned in this article

Does Arcturus Therapeutics Holdings Inc (ARCT) Have What it Takes to be in Your Portfolio Wednesday?

A rating of 91 puts Arcturus Therapeutics Holdings Inc (ARCT) near the top of the Biotechnology industry according to InvestorsObserver. Arcturus Therapeutics Holdings Inc's score of 91 means it scores higher than 91% of stocks in the industry. Arcturus Therapeutics Holdings Inc also received an overall rating of 80, putting it above 80% of all stocks. Biotechnology is ranked 15 out of the 148 industries.

Overall Score - 80
ARCT has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on ARCT!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Arcturus Therapeutics Holdings Inc Stock Today?

Arcturus Therapeutics Holdings Inc (ARCT) stock has risen 3.48% while the S&P 500 is lower by -0.4% as of 1:13 PM on Wednesday, Jun 7. ARCT has gained $0.93 from the previous closing price of $26.75 on volume of 139,875 shares. Over the past year the S&P 500 has gained 2.55% while ARCT has gained 41.66%. ARCT earned $3.75 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 7.39. Click Here to get the full Stock Report for Arcturus Therapeutics Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App